10X Genomics reported a GAAP loss of $42.413 million for the 3 months of 2022, up 3.7 times from $11.551 million in the prior year. Revenue increased 8.2% to $114.496 million from $105.821 million a year earlier.
10X Genomics reported a GAAP loss of $42.413 million for the 3 months of 2022, up 3.7 times from $11.551 million in the prior year. Revenue increased 8.2% to $114.496 million from $105.821 million a year earlier. 
investors.10xgenomics.com
English (US) 